All In Biotech

Investigational drug · Phase 2

zamtocabtagene autoleucel

Also called: MB-CART2019.1

Not approved by FDA. In 5 industry-sponsored Phase 2 or 3 trials that are active or finished in the last two years, most often for CAR T Cell Therapy, Mantle Cell Lymphoma (MCL), Multiple Sclerosis.

Phase 2

Last checked: Nov 20, 2026Latest source record: Jul 13, 2026 (newest trial update)Source: ClinicalTrials.govMethods & limitations

Highest phase

Phase 2

Industry-sponsored trials

Phase 2 and 3 trials

5

5 still active

All registered trials

5

Any phase or sponsor naming "zamtocabtagene autoleucel"

First trial start

2021

May 25, 2021

Sponsors

Lead sponsors of its Phase 2 and 3 trials.

All registered trials by phase

Every ClinicalTrials.gov drug study naming "zamtocabtagene autoleucel", any sponsor or status.

Conditions studied

As listed on its trial records.

  • CAR T Cell Therapy
  • Mantle Cell Lymphoma (MCL)
  • Multiple Sclerosis
  • DLBCL - Diffuse Large B Cell Lymphoma
  • B-Cell Neoplasm
  • Refractory Diffuse Large B Cell Lymphoma (DLBCL)
  • Relapsed Diffuse Large B Cell Lymphoma
  • High Grade B-cell Lymphoma (HGBCL)
  • Primary Mediastinal B-cell Lymphoma (PMBCL)
  • Transformed Lymphoma

Approved drugs for the same conditions: Lymphoma (non-Hodgkin) · Multiple sclerosis · Oncology · Hematology and blood cancers · Neurology

Largest trials

Live from ClinicalTrials.gov: studies naming "zamtocabtagene autoleucel" as an intervention, largest first.

All trials

Newest research

PubMed records naming it or its code names, newest first.

All 6 on PubMed

Names are merged from how sponsors list this drug on ClinicalTrials.gov, so an alias can occasionally belong to a related compound. Development status changes faster than registry records do.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.